ArticleEuropean urology2024

Re: Which Patients with Metastatic Hormone-sensitive Prostate Cancer Benefit from Docetaxel: A Systematic Review and Meta-analysis of Individual Participant Data from Randomised Trials.

Daniele Raggi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.